Orchestra BioMed Holdings, Inc.
OBIO
$4.49
-$0.08-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.64% | -30.19% | -25.41% | -28.41% | -24.23% |
| Total Depreciation and Amortization | 6.17% | 11.15% | 11.34% | 9.31% | 7.32% |
| Total Amortization of Deferred Charges | 593.55% | 5,966.67% | 215.38% | 1.32% | -72.32% |
| Total Other Non-Cash Items | 24.57% | 54.99% | 39.92% | 64.98% | 84.58% |
| Change in Net Operating Assets | -1,255.82% | 13.28% | -251.90% | 110.90% | 76.87% |
| Cash from Operations | 3.15% | -25.50% | -33.21% | -20.51% | -9.61% |
| Capital Expenditure | -69.20% | -212.22% | -144.27% | -670.59% | -270.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -289.21% | -123.55% | -56.68% | -64.71% | 29.87% |
| Cash from Investing | -305.83% | -125.97% | -58.07% | -66.33% | 22.48% |
| Total Debt Issued | 33.33% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 288.96% | 276.68% | 4,286.42% | 5,780.46% | 5,913.78% |
| Repurchase of Common Stock | -182.18% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -276.53% | -- | -- | -- | -100.98% |
| Cash from Financing | 202.81% | 1,879.24% | 369.05% | 372.54% | -36.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 249.78% | 151.37% | -167.96% | -207.50% | -177.01% |